Fluge and Mella seem to be working at almost lightning speed. Besides managing their huge Rituximab study (and all the sub- studies within it) and the cyclophosphamide trial, they’re also carrying out large research studies. For years, of course, some...

The day after my brother’s wedding I shot down to San Diego to meet Rachel Riggs and a doctor with ME/CFS. Rachel, who has turned into a volunteer patient coordinator had enrolled me in Naviaux’s next metabolomics study. (Resistance, I quickly surmised,...

“The pathological nature of the fatigue experienced by ME/CFS sufferers is its inexplicable persistence, severity and its inability to be sufficiently relieved by rest.” Armstrong et. al. The Naviaux metabolomics study with its findings suggesting that a hypometabolic...

Fluge and Mella are best known for their Rituximab work, but just last week Mella reported that they’d found a hypometabolic state in ME/CFS as well. Check out that along with what’s going on with Rituximab, and another chemotherapy/autoimmune drug that...

Within days of Naviaux’s possibly groundbreaking metabolomics paper, Maureen Hanson told a SolveME/CFS Initiative webinar audience that her metabolomics study indicated ME/CFS was a hypometabolic disorder as well. Check out what she found plus learn about her...

Thanks to yet another major donation to the Open Medicine Foundation, the OMF’s “Mitochondria Man”, Robert Naviaux, is moving forward with a major study. Across the Atlantic, the UK’s “Grand Challenge” – potentially the...